0001171843-15-000934.txt : 20150219 0001171843-15-000934.hdr.sgml : 20150219 20150219160544 ACCESSION NUMBER: 0001171843-15-000934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150218 FILED AS OF DATE: 20150219 DATE AS OF CHANGE: 20150219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKORN INC CENTRAL INDEX KEY: 0000003116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 720717400 STATE OF INCORPORATION: LA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847-279-6100 MAIL ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONACCORSI JOSEPH CENTRAL INDEX KEY: 0001234712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32360 FILM NUMBER: 15631791 MAIL ADDRESS: STREET 1: 485 HALF DAY ROAD SUITE 300 CITY: BUFFALO GROVE STATE: IL ZIP: 60089-6548 4 1 formfour.xml X0306 4 2015-02-18 0 0000003116 AKORN INC AKRX 0001234712 BONACCORSI JOSEPH 1925 WEST FIELD COURT SUITE 300 LAKE FOREST IL 60045 0 1 0 0 Secretary Common Stock 2015-02-18 4 M 0 7500 1.46 A 319189 D Common Stock 2015-02-18 4 M 0 92500 1.46 A 411689 D Common Stock 2015-02-18 4 S 0 40827 47.33 D 370862 D Stock Option (right to buy) 1.46 2015-02-18 4 M 0 7500 0 D 2015-02-22 Common Stock 7500 92500 D Stock Option (right to buy) 1.46 2015-02-18 4 M 0 92500 0 D 2015-02-22 Common Stock 92500 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2014. Upon execution of transactions disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms. All proceeds from the sale were used to cover exercise price and taxes due upon exercise of options. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $46.80 to $48.49 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range. Amount of Shares Beneficially Owned Following Reported Transaction includes 104,414 unvested shares subject to a restricted stock awards and 266,448 shares owned outright. Shares owned outright include 1,015 shares acquired through participation in the Employee Stock Purchase Plan for the 2014 plan year. The option vested in three annual installments with 33,333 options vesting on each of February 22, 2011 and February 22, 2012, and 33,334 options vesting on February 22, 2013. Exercise of stock options that were approaching their 5-year expiration date. There was no consideration given in exchange for the security. /s/ Joseph Bonaccorsi 2015-02-19